Alerje
Biotechnology · Cell & Gene Therapy
$1.9Mlatest round · Venture round · Jul 2023 · 3 yr ago
3backers · Backstage Capital, Chloe Capital
$1.3Mgrants · 3 grants · CORDIS
1-10team · employees, estimated range
Overview
FAIT connects clinics and families through the allergy treatment journey with AI powered insights, proactive monitoring, and seamless communication.
Funding and backers
Total raised
$1.9M
5 rounds on record
Latest round
$1.9M
Venture round · Jul 2023 · 3 yr ago
Team
1-10
employees, estimated range
Grants
$1.3M
3 grants · CORDIS
Backers
3
Backstage Capital, Chloe Capital
The money's age
Long since its last round
39 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 11, 2023
Won a grant $75k · CORDIS
Sep 15, 2023
Won a grant $1M · CORDIS
Jul 1, 2021
Won a grant $255k · CORDIS
May 12, 2020
Took on debt financing $75k · SEC Form D
2016
Founded
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Dec 2023 | $75k | — | CORDIS |
| Grant | Sep 2023 | $1M | — | CORDIS |
| Venture round | Jul 2023 | $1.9M | — | SEC Form D |
| Grant | Jul 2021 | $255k | — | CORDIS |
| Debt Financing | May 2020 | $75k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Alerje, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Javier EvelynExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

The #1 online at-home allergy clinic that offers the most affordable and convenient allergy treatment including sublingual allergy drops &…

At AllergenIQ, our allergist offers at-home allergy testing and tailored treatment plans for kids and parents. Book your virtual…

At Jaguar Gene Therapy, we believe in a world where patients and families won’t have to hear those words. Our mission is to accelerate…

Transforming disease treatment through cell and gene therapy. Join us at BlueRock to discover our cutting-edge science & clinical programs.

Gain unprecedented kinetic insights into your CRISPR workflow with the CRISPR QC’s analytics platform.

REPROSENT creates the human-signal layer in oncology, turning patient symptoms into computable data for safer, more precise treatment…
People

Javier Evelyn
Executive Officer, Director

Patti Glaza
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Mitsubishi et Alerje annoncent un partenariat stratégique pour révolutionner le traitement des allergies
Read more
Report
Expanding Our Mission: Alerje Tackles Opioid Crisis in Military and Veteran Communities, Leveraging Proven AI Tech for Rapid Naloxone Distribution
Read more
Report
Alerje Earns $1M Phase II SBIR NSF Award to Support Life Changing Food Allergy Immunotherapy for Food Allergies with AI Powered App Platform
Read more
Report
Alerje founder thinks there's a smarter way to carry allergy medicine
The startup, which has raised more than $250,000 in funding, is working on a smartphone case that carries a slim epinephrine auto-injector.
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Detroit
United States
HQ
1-10 est. staff

Backstage Capital
Chloe Capital
JumpStart Nova 




